dengue
How The Dengue Virus Opens Up To Human Hosts
The change in temperature when dengue viruses enter a human from a mosquito host cause structural changes that expose weak spots.
Promising Results For Takeda’s Dengue Vaccine
Takeda's dengue vaccine has proven to be safe and able to produce an antibody response against all four serotypes of dengue in an interim analysis of their ongoing Phase 2 trial.
A*STAR & Chugai’s Anti-Dengue Antibody Project Receives GHIT Funding
The Global Health Innovative Technology Fund has awarded a US$5.3 million grant to help develop an antibody that can neutralize all four dengue serotypes.
7 Inspiring Scientists Who Happen To Be Women
These seven women have all overcome the odds to become leaders in their own fields.
India Embraces Eliminate Dengue’s Wolbachia Program
India joins Brazil, Australia, Indonesia, Vietnam and Colombia to become the sixth country in the Eliminate Dengue Program using the Wolbachia method.
What You Need To Know About Takeda’s Dengue Vaccine
Derek Wallace, global dengue program medical director of Takeda Pharmaceutical Company, on the company's plans for dengue and Zika vaccines.
7 Must-Read Stories In November 2016
Gut-inspired batteries, dengue vaccines and future-proof jobs were popular reads last month.
To Neutralize Zika, First Disrupt The Cell Infection Process
Researchers have discovered the mechanism by which a human antibody prevents Zika infection at the cellular level.
What You Need To Know About Dengvaxia, Sanofi Pasteur’s Dengue Vaccine
Dr. Ng Su-Peing, global medical head of Sanofi Pasteur, explains how Dengvaxia can address the burden of dengue around the world.
